Huang Hsin Hua News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Huang hsin hua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Huang Hsin Hua Today - Breaking & Trending Today
Over 360 aftershocks strike Taiwan following magnitude 7.2 quake focustaiwan.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from focustaiwan.tw Daily Mail and Mail on Sunday newspapers.
Authorities in Taiwan recently detected radioactive substances in a batch of konjaku jelly powder imported from Gunma prefecture, one of the five prefectures in Japan around the site of the 2011 Fukushima nuclear disaster. Although the amount is within local security limits, the issue stirred up public concerns over security of the so-called ....
Majority backs cash subsidies: survey taipeitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taipeitimes.com Daily Mail and Mail on Sunday newspapers.
Moderna, Pfizer-BNT COVID vaccines most popular in Taiwan: poll focustaiwan.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from focustaiwan.tw Daily Mail and Mail on Sunday newspapers.
The Chinese Nationalist Party (KMT)-affiliated National Policy Foundation yesterday questioned the safety and effectiveness of COVID-19 vaccine candidates from Medigen Vaccine Biologics Corp, citing a lack of phase 3 trials. Foundation deputy director Huang Hsin-hua (黃心華) made the remarks in an online news conference a day after Medigen unblinded data from its phase 2 trials. Although Medigen increased the sample pool of subjects in its phase 2 clinical tests in a bid to secure emergency use authorization, an expanded phase 2 is no substitute for phase 3 trials, Huang said. The lack of phase 3 studies sets the Taiwan-made vaccines apart from those ....